These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 38825162)

  • 21. The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].
    Sundararajan V; Sarkar FH; Ramasamy TS
    Cell Oncol (Dordr); 2018 Jun; 41(3):223-252. PubMed ID: 29667069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The potential of exosomes in immunotherapy.
    Chaput N; Taïeb J; André F; Zitvogel L
    Expert Opin Biol Ther; 2005 Jun; 5(6):737-47. PubMed ID: 15952905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes-based cell-free cancer therapy: a novel strategy for targeted therapy.
    Dutta A
    Immunol Med; 2021 Jun; 44(2):116-123. PubMed ID: 32924880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cell-derived exosomes for cancer immunotherapy: what's next?
    Viaud S; Théry C; Ploix S; Tursz T; Lapierre V; Lantz O; Zitvogel L; Chaput N
    Cancer Res; 2010 Feb; 70(4):1281-5. PubMed ID: 20145139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of exosomes on tumor immunomodulation and their potential clinical applications (Review).
    Li M; Cai H; Deng R; Cheng J; Shi Y
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36222307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exosome may be the next generation of promising cell-free vaccines.
    Dai Z; Cai R; Zeng H; Zhu H; Dou Y; Sun S
    Hum Vaccin Immunother; 2024 Dec; 20(1):2345940. PubMed ID: 38714324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Comprehensive Review on Exosome: Recent Progress and Outlook.
    Agarwal P; Anees A; Harsiddharay RK; Kumar P; Tripathi PK
    Pharm Nanotechnol; 2023 May; ():. PubMed ID: 37231760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
    Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
    Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The application of exosomes as a nanoscale cancer vaccine.
    Tan A; De La Peña H; Seifalian AM
    Int J Nanomedicine; 2010 Nov; 5():889-900. PubMed ID: 21116329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging role of exosomes as novel therapeutics: Biology, technologies, clinical applications, and the next.
    Song Y; Kim Y; Ha S; Sheller-Miller S; Yoo J; Choi C; Park CH
    Am J Reprod Immunol; 2021 Feb; 85(2):e13329. PubMed ID: 32846024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered exosomes emerging from muscle cells break immune tolerance to HER2 in transgenic mice and induce antigen-specific CTLs upon challenge by human dendritic cells.
    Anticoli S; Aricò E; Arenaccio C; Manfredi F; Chiozzini C; Olivetta E; Ferrantelli F; Lattanzi L; D'Urso MT; Proietti E; Federico M
    J Mol Med (Berl); 2018 Feb; 96(2):211-221. PubMed ID: 29282521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Harnessing the exosome-induced immune response for cancer immunotherapy.
    Gehrmann U; Näslund TI; Hiltbrunner S; Larssen P; Gabrielsson S
    Semin Cancer Biol; 2014 Oct; 28():58-67. PubMed ID: 24859748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Comprehensive Review on Factors Influences Biogenesis, Functions, Therapeutic and Clinical Implications of Exosomes.
    Gurunathan S; Kang MH; Kim JH
    Int J Nanomedicine; 2021; 16():1281-1312. PubMed ID: 33628021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle.
    Yan W; Jiang S
    Trends Cancer; 2020 Jun; 6(6):506-517. PubMed ID: 32460004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: cancer immunotherapy by exosome-based vaccines.
    Hao S; Moyana T; Xiang J
    Cancer Biother Radiopharm; 2007 Oct; 22(5):692-703. PubMed ID: 17979572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosome-based immunotherapy.
    Chaput N; Taïeb J; Schartz NE; André F; Angevin E; Zitvogel L
    Cancer Immunol Immunother; 2004 Mar; 53(3):234-9. PubMed ID: 14727085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The exosomes in tumor immunity.
    Liu Y; Gu Y; Cao X
    Oncoimmunology; 2015 Sep; 4(9):e1027472. PubMed ID: 26405598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A; Spyridopoulou K; Pappa A; Chlichlia K
    Pharmacol Ther; 2016 Sep; 165():32-49. PubMed ID: 27235391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclophosphamide enhances the release of tumor exosomes that elicit a specific immune response in vivo in a murine T-cell lymphoma.
    Cocozza F; Menay F; Tsacalian R; Elisei A; Sampedro P; Soria I; Waldner C; Gravisaco MJ; Mongini C
    Vaccine; 2019 Mar; 37(12):1565-1576. PubMed ID: 30777349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomes in cancer development, metastasis, and immunity.
    Zhang L; Yu D
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):455-468. PubMed ID: 31047959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.